↓ Skip to main content

Current Advances in Osteosarcoma

Overview of attention for book
Cover of 'Current Advances in Osteosarcoma'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Historical Perspective on the Introduction and Use of Chemotherapy for the Treatment of Osteosarcoma
  3. Altmetric Badge
    Chapter 2 Wnt Signaling in Osteosarcoma.
  4. Altmetric Badge
    Chapter 3 Receptor Tyrosine Kinases in Osteosarcoma: Not Just the Usual Suspects.
  5. Altmetric Badge
    Chapter 4 Understanding the role of notch in osteosarcoma.
  6. Altmetric Badge
    Chapter 5 Developmental Pathways Hijacked by Osteosarcoma
  7. Altmetric Badge
    Chapter 6 MicroRNAs in Osteosarcomagenesis
  8. Altmetric Badge
    Chapter 7 RECQ DNA Helicases and Osteosarcoma
  9. Altmetric Badge
    Chapter 8 Autophagy in Osteosarcoma
  10. Altmetric Badge
    Chapter 9 HER-2 Involvement in Osteosarcoma
  11. Altmetric Badge
    Chapter 10 Role of Ezrin in Osteosarcoma Metastasis
  12. Altmetric Badge
    Chapter 11 Participation of the Fas/FasL Signaling Pathway and the Lung Microenvironment in the Development of Osteosarcoma Lung Metastases
  13. Altmetric Badge
    Chapter 12 Zebrafish as a Model for Human Osteosarcoma
  14. Altmetric Badge
    Chapter 13 Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks?
  15. Altmetric Badge
    Chapter 14 Oncolytic Viruses for Potential Osteosarcoma Therapy
  16. Altmetric Badge
    Chapter 15 IL-11Rα: A Novel Target for the Treatment of Osteosarcoma.
  17. Altmetric Badge
    Chapter 16 Bone-Seeking Radiopharmaceuticals as Targeted Agents of Osteosarcoma: Samarium-153-EDTMP and Radium-223
  18. Altmetric Badge
    Chapter 17 Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma
  19. Altmetric Badge
    Chapter 18 Genetically modified T-cell therapy for osteosarcoma.
  20. Altmetric Badge
    Chapter 19 Natural Killer Cells for Osteosarcoma.
  21. Altmetric Badge
    Chapter 20 Erratum
Attention for Chapter 15: IL-11Rα: A Novel Target for the Treatment of Osteosarcoma.
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
IL-11Rα: A Novel Target for the Treatment of Osteosarcoma.
Chapter number 15
Book title
Current Advances in Osteosarcoma
Published in
Advances in experimental medicine and biology, May 2014
DOI 10.1007/978-3-319-04843-7_15
Pubmed ID
Book ISBNs
978-3-31-904842-0, 978-3-31-904843-7
Authors

Lewis VO, Lewis, Valerae O., Valerae O. Lewis

Abstract

Recent advances have shown that cell surface receptors are expressed differentially in normal and pathological conditions. Novel organ specific and disease specific proteins expressed on tumor vasculature have been identified by in vivo phage display technology and the diversity of the tumor-associated vasculature has provided the basis for the development of targeted therapeutics. Investigators recently screened a phage display library in a human cancer patient. An IL-11 mimic phage displaying the cyclic peptide CGRRAGGSC (single letter amino acid code) specifically bound to immobilized IL-11Rα. It has been demonstrated that the expression of the IL-11Rα is increased in several other types of tumors including osteosarcoma. The ability to selectively target the IL-11Rα may provide an alternative treatment of for a disease where new treatment options are truly needed.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 22%
Professor 1 11%
Student > Postgraduate 1 11%
Student > Doctoral Student 1 11%
Unknown 4 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 11%
Agricultural and Biological Sciences 1 11%
Medicine and Dentistry 1 11%
Design 1 11%
Unknown 5 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2014.
All research outputs
#18,373,576
of 22,757,090 outputs
Outputs from Advances in experimental medicine and biology
#3,304
of 4,926 outputs
Outputs of similar age
#164,542
of 227,755 outputs
Outputs of similar age from Advances in experimental medicine and biology
#32
of 39 outputs
Altmetric has tracked 22,757,090 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,926 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,755 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.